BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15534881)

  • 21. Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A.
    Creutzig U; Büchner T; Sauerland MC; Zimmermann M; Reinhardt D; Döhner H; Schlenk RF
    Cancer; 2008 Feb; 112(3):562-71. PubMed ID: 18076087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unique clinical and biological features of leukemia in Down syndrome children.
    Xavier AC; Ge Y; Taub J
    Expert Rev Hematol; 2010 Apr; 3(2):175-86. PubMed ID: 21083461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extramedullary infiltration at diagnosis and prognosis in children with acute myelogenous leukemia.
    Kobayashi R; Tawa A; Hanada R; Horibe K; Tsuchida M; Tsukimoto I;
    Pediatr Blood Cancer; 2007 Apr; 48(4):393-8. PubMed ID: 16550530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Down's syndrome and leukemia].
    Bermúdez Cortés M; Verdeguer Miralles A; Jovaní Casano C; Cañete Nieto A; Fernández JM; Ferris Tortajada J; Castel Sánchez V
    An Esp Pediatr; 1998 Jun; 48(6):593-8. PubMed ID: 9662842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloid leukaemia in children with Down syndrome: report of the registry-based French experience between 1990 and 2003.
    Tandonnet J; Clavel J; Baruchel A; Nacka F; Pérel Y
    Pediatr Blood Cancer; 2010 Jul; 54(7):927-33. PubMed ID: 20405513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trials.
    Rao A; Hills RK; Stiller C; Gibson BE; de Graaf SS; Hann IM; O'Marcaigh A; Wheatley K; Webb DK
    Br J Haematol; 2006 Mar; 132(5):576-83. PubMed ID: 16445830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced metabolism of 1-beta-D-arabinofuranosylcytosine in Down syndrome cells: a contributing factor to the superior event free survival of Down syndrome children with acute myeloid leukemia.
    Taub JW; Matherly LH; Stout ML; Buck SA; Gurney JG; Ravindranath Y
    Blood; 1996 Apr; 87(8):3395-403. PubMed ID: 8605357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute leukemias in children with Down syndrome.
    Zwaan MC; Reinhardt D; Hitzler J; Vyas P
    Pediatr Clin North Am; 2008 Feb; 55(1):53-70, x. PubMed ID: 18242315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiomyopathy in children with Down syndrome treated for acute myeloid leukemia: a report from the Children's Oncology Group Study POG 9421.
    O'Brien MM; Taub JW; Chang MN; Massey GV; Stine KC; Raimondi SC; Becton D; Ravindranath Y; Dahl GV;
    J Clin Oncol; 2008 Jan; 26(3):414-20. PubMed ID: 18202418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term results of an ultra low-dose cytarabine-based regimen for the treatment of acute megakaryoblastic leukaemia in children with Down syndrome.
    Al-Ahmari A; Shah N; Sung L; Zipursky A; Hitzler J
    Br J Haematol; 2006 Jun; 133(6):646-8. PubMed ID: 16704441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?
    Larson RA
    Best Pract Res Clin Haematol; 2007 Mar; 20(1):29-37. PubMed ID: 17336252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia.
    Baz R; Rodriguez C; Fu AZ; Jawde RA; Kalaycio M; Advani A; Sobecks R; Sekeres MA
    Cancer; 2007 Oct; 110(8):1752-9. PubMed ID: 17724726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study.
    Marcucci G; Mrózek K; Ruppert AS; Maharry K; Kolitz JE; Moore JO; Mayer RJ; Pettenati MJ; Powell BL; Edwards CG; Sterling LJ; Vardiman JW; Schiffer CA; Carroll AJ; Larson RA; Bloomfield CD
    J Clin Oncol; 2005 Aug; 23(24):5705-17. PubMed ID: 16110030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transient myeloproliferative syndrome/transient acute myeloid leukemia in a newborn with Down syndrome: a case report and literature review.
    D'Angelo G; Merlo P
    Lab Hematol; 2003; 9(1):38-41. PubMed ID: 12661826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcomes of de novo acute myeloid leukemia in Thai patients.
    Niparuck P; Chuncharunee S; Ungkanont A; Udomtrupayakul U; Aungchaisuksiri P; Rerkamnuatchoke B; Jootar S; Atichartakarn V
    J Med Assoc Thai; 2009 Sep; 92(9):1143-9. PubMed ID: 19772172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute lymphoblastic leukemia and Down syndrome: presenting features and treatment outcome in the experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP).
    Arico M; Ziino O; Valsecchi MG; Cazzaniga G; Baronci C; Messina C; Pession A; Santoro N; Basso G; Conter V;
    Cancer; 2008 Aug; 113(3):515-21. PubMed ID: 18521927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group.
    Tsukimoto I; Tawa A; Horibe K; Tabuchi K; Kigasawa H; Tsuchida M; Yabe H; Nakayama H; Kudo K; Kobayashi R; Hamamoto K; Imaizumi M; Morimoto A; Tsuchiya S; Hanada R
    J Clin Oncol; 2009 Aug; 27(24):4007-13. PubMed ID: 19620491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acute myeloid leukemia].
    Tabuchi K
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):156-61. PubMed ID: 17301520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children's Cancer Group Studies 2861 and 2891.
    Lange BJ; Kobrinsky N; Barnard DR; Arthur DC; Buckley JD; Howells WB; Gold S; Sanders J; Neudorf S; Smith FO; Woods WG
    Blood; 1998 Jan; 91(2):608-15. PubMed ID: 9427716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group.
    Barnard DR; Alonzo TA; Gerbing RB; Lange B; Woods WG;
    Pediatr Blood Cancer; 2007 Jul; 49(1):17-22. PubMed ID: 16856158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.